EMEA-002115-PIP01-17-M05
Key facts
| Invented name |
Dovprela (previously Pretomanid FGK)
|
| Active substance |
Pretomanid
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0292/2022
|
| PIP number |
EMEA-002115-PIP01-17-M05
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of multi-drug-resistant tuberculosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Global Alliance for TB Drug Development
Tel. +1 2122277450 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|